Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expanding the Arsenal of PtIV Anticancer Agents: Multi‐action PtIV Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group
Thirumal Yempala, Tomer Babu, Subhendu Karmakar, et al.
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 50, pp. 18218-18223
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Latest developments in metal complexes as anticancer agents
Renata Paprocka, Małgorzata Wiese-Szadkowska, Sabina Janciauskiene, et al.
Coordination Chemistry Reviews (2021) Vol. 452, pp. 214307-214307
Closed Access | Times Cited: 185
Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs
Zoufeng Xu, Zhigang Wang, Zhiqin Deng, et al.
Coordination Chemistry Reviews (2021) Vol. 442, pp. 213991-213991
Closed Access | Times Cited: 123
What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives
Kun Peng, Bing‐Bing Liang, Wenting Liu, et al.
Coordination Chemistry Reviews (2021) Vol. 449, pp. 214210-214210
Closed Access | Times Cited: 120
An ultrasound-activatable platinum prodrug for sono-sensitized chemotherapy
Gongyuan Liu, Yachao Zhang, Houzong Yao, et al.
Science Advances (2023) Vol. 9, Iss. 25
Open Access | Times Cited: 42
An NIR Discrete Metallacycle Constructed from Perylene Bisimide and Tetraphenylethylene Fluorophores for Imaging‐Guided Cancer Radio‐Chemotherapy
Yuan Ding, Zongrui Tong, Lulu Jin, et al.
Advanced Materials (2021) Vol. 34, Iss. 7
Closed Access | Times Cited: 103
Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?
Dan Gibson
Journal of Inorganic Biochemistry (2021) Vol. 217, pp. 111353-111353
Closed Access | Times Cited: 90
A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance
Philipp Fronik, Michael Gutmann, Petra Vician, et al.
Communications Chemistry (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 44
Oxaliplatin and its derivatives – An overview
Paul O'Dowd, Darragh F. Sutcliffe, Darren M. Griffith
Coordination Chemistry Reviews (2023) Vol. 497, pp. 215439-215439
Open Access | Times Cited: 33
Recent updates in nanoscale delivery systems of platinum(IV) antitumor prodrugs
Zhiyuan Zhou, Pengmin Shi, Changli Wang, et al.
Coordination Chemistry Reviews (2024) Vol. 508, pp. 215774-215774
Closed Access | Times Cited: 13
Advancements in platinum-based anticancer drug development: A comprehensive review of strategies, discoveries, and future perspectives
Debsankar Sahoo, Priya Deb, Tamal Basu, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117894-117894
Closed Access | Times Cited: 12
Cisplatin-eugenol Pt(IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacy
Vojtěch Novohradský, Tomer Babu, Hana Kostrhunová, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117854-117854
Closed Access | Times Cited: 1
Strategies for the Improvement of Metal-Based Chemotherapeutic Treatments
Damiano Cirri, Francesco Bartoli, Alessandro Pratesi, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 504-504
Open Access | Times Cited: 46
Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities
Mauro Ravera, Elisabetta Gabano, Michael J. McGlinchey, et al.
Dalton Transactions (2021) Vol. 51, Iss. 6, pp. 2121-2134
Closed Access | Times Cited: 46
Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?
Claudia Schmidt, Tomer Babu, Hana Kostrhunová, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 15, pp. 11364-11378
Closed Access | Times Cited: 43
CuS Nanoparticles-Loaded and Cisplatin Prodrug Conjugated Fe(III)–MOFs for MRI-Guided Combination of Chemotherapy and NIR-II Photothermal Therapy
Sufeng Qiang, Xiaochun Hu, Ruihao Li, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 32, pp. 36503-36514
Closed Access | Times Cited: 31
Flavin-Conjugated Pt(IV) Anticancer Agents
Juan Sánchez-Camacho, Sonia Infante-Tadeo, Ana C. Carrasco, et al.
Inorganic Chemistry (2023) Vol. 62, Iss. 14, pp. 5644-5651
Open Access | Times Cited: 22
Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands
Pavel Štarha, Radka Křikavová
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215578-215578
Closed Access | Times Cited: 22
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death
Amrita Sarkar, Vojtěch Novohradský, Moumita Maji, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 42
Open Access | Times Cited: 20
Multitargeted Platinum(IV) Anticancer Complexes Bearing Pyridinyl Ligands as Axial Leaving Groups
Qiyuan Zhou, Shu Chen, Zoufeng Xu, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 18
Closed Access | Times Cited: 18
Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance
Meng Wang, Guimei Li, Guiyang Jiang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6218-6237
Closed Access | Times Cited: 8
Ferroptosis Inducing Co(III) Polypyridine Sulfasalazine Complex for Therapeutically Enhanced Anticancer Therapy
Nicolás Montesdeoca, Lukas Johannknecht, Elizaveta Efanova, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 48
Open Access | Times Cited: 8
Polymeric Encapsulation of a Ru(II)-Based Photosensitizer for Folate-Targeted Photodynamic Therapy of Drug Resistant Cancers
Johannes Karges, Mickaël Tharaud, Gilles Gasser
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 8, pp. 4612-4622
Open Access | Times Cited: 37
Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes
Alfonso Annunziata, Angela Amoresano, Maria Elena Cucciolito, et al.
Inorganic Chemistry (2020) Vol. 59, Iss. 6, pp. 4002-4014
Open Access | Times Cited: 36
Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer Cells
Subhendu Karmakar, Hana Kostrhunová, Tereza Ctvrtlikova, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 22, pp. 13861-13877
Closed Access | Times Cited: 36
Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments
Ester Giorgi, Francesca Binacchi, Carlo Marotta, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 273-273
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top